CHRONIC

Brand Owner (click to sort) Address Description
CRONIC FLEEK 064 Ponce de Leon Ave Suite 507 San Juan 00907 Puerto Rico CHRONIC;Software as a service (SAAS) services featuring software for development of web and mobile applications, blockchain applications, and decentralized applications (DApps); Software as a service (SAAS) services featuring software for providing web services needed to run cron jobs, web hooks, subscriptions, and serverless functions on the internet, open web, smart contracts, canisters, and related technologies;
KRONIC Ian Donald 179 St Joseph Ave Long Beach CA 90803 CHRONIC;Distilled Spirits;
KRONIC CLOTHING Direct Components 109 W 17th Street Cheyenne WY 82001 CHRONIC;MEN'S AND WOMEN'S CLOTHING, NAMELY, SHIRTS, SWEAT SHIRTS, T-SHIRTS, TANK TOPS, PANTS, SNOW PANTS, JACKETS, SPORT COATS, SHORTS, HATS AND BEANIES;CLOTHING;
KRONIK WINERY EXCHANGE, INC. 500 Redwood Blvd., Suite 200 Novato CA 94947 CHRONIC;Distilled Spirits;
KRONIK Bryan Clark C/O Accelerate IP LLC 11028 E Quarry Ave Mesa AZ 85212 CHRONIC;Bomber jackets; Hoodies; T-shirts; Graphic T-shirts; Long-sleeved shirts; Short-sleeved shirts; Short-sleeved or long-sleeved t-shirts; Tee shirts;The English translation of Kronik in the mark is Chronic.;
KRONIQ Mustafa Wafa 6830 Isaac Court Chino CA 91710 CHRONIC;Non-alcoholic beer; Non-alcoholic beer flavored beverages; Non-alcoholic carbonated beverages; Non-alcoholic cocktails; Non-alcoholic sparkling fruit juice beverages;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to defined peptides and the quantitative determination thereof in body fluids of patients suffering from progredient chronic dementia, in relation to the concentration of said peptides in a control group. The inventive peptides come from a protein precursor having the corresponding gene, are processed in a specific manner, and are optionally post-translationally modified, especially phosphorylized. An increase in the concentrations of these peptides or the corresponding non-processed protein indicates progredient chronic dementia. Progredient chronic dementia is detected by identifying the peptides and/or the protein individually or in combinations. The invention also relates to the use of said peptides for controlling the course of progredient chronic dementia and for the prognosis of progredient chronic dementia, especially for complementing or replacing mini-mental scores, and for developing therapeutic agents to combat progredient chronic dementia such as Alzheimer's disease.